Comparative profiling of immune genes improves the prognoses of lower grade gliomas

Objective: Lower grade gliomas (LGGs), classified as World Health Organization (WHO) grade II and grade III gliomas, comprise a heterogeneous group with a median survival time ranging from 4–13 years. Accurate prediction of the survival times of LGGs remains a major challenge in clinical practice. M...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Zhiliang Wang, Wen Cheng, Zheng Zhao, Zheng Wang, Chuanbao Zhang, Guanzhang Li, Anhua Wu, Tao Jiang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	China Anti-Cancer Association 2022-04-01
סדרה:	Cancer Biology & Medicine
נושאים:	lower grade glioma immune gene pairs signature prognosis
גישה מקוונת:	https://www.cancerbiomed.org/content/19/4/533
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!